Share articleAs U.S. lawmakers debate issues around health care for transgender youth, it’s been difficult to determine the ...

Researchers say among those with private insurance, not one transgender person under 12 was prescribed gender-affirming hormones. “There’s not some massive wave of folks accessing care,” the report's ...

The study, published in JAMA Pediatrics on Monday, looked at private insurance claims representing over 5 million patients in ...

A new analysis of private insurance claims data finds less than 0.1% of youth accessed puberty blockers or hormones for ...

Fewer than 1 in 1,000 U.S. adolescents with commercial insurance received gender-affirming medications -- puberty blockers or ...

Less than 1 in 1,000 adolescents with commercial insurance received gender-affirming medication over a five-year period, ...